Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
| Revenue growth | | | | | -100.0% | 666.7% | -90.3% | 55.0% |
| Cost of goods sold | 5.7 | 1.6 | 4.3 | 3.6 | 0.0 | 0.0 | -44.8 | -9.4 |
| Gross profit | -5.7 | -1.6 | -4.3 | -3.6 | 0.0 | 0.0 | 44.8 | 9.5 |
| Gross margin | | | | | | 58.7% | 745966.7% | 15271.0% |
| Selling, general and administrative | 140.3 | 0.0 | 0.0 | | 0.0 | | | |
| Research and development | | | | | | 4.1 | 11.2 | 3.3 |
| General and administrative | | 0.0 | 0.0 | 3.0 | 0.0 | 4.8 | 11.2 | 1.4 |
| EBIT | 140.3 | 0.0 | 0.0 | 0.0 | 0.0 | 9.0 | 22.4 | 4.7 |
| EBIT margin | | | | | | 19571.7% | 372933.3% | 7585.5% |
| Pre-tax income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net margin | | | | | | 0.0% | 0.0% | 0.0% |
| |
| Diluted EPS | | | | $0.00 | $0.00 | | | |
| Shares outstanding (diluted) | | | | 91.1 | 56.5 | | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|